Upgrade to SI Premium - Free Trial

NextCure, Inc. (NXTC) Misses Q2 EPS by 17c

August 2, 2024 3:59 AM

NextCure, Inc. (NASDAQ: NXTC) reported Q2 EPS of ($0.55), $0.17 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

Categories

Earnings